The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium (Q37078647)
Jump to navigation
Jump to search
scientific article published on 20 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium |
scientific article published on 20 April 2011 |
Statements
1 reference
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium (English)
1 reference
Steven E Lipshultz
1 reference
Lynda M Vrooman
1 reference
Donna S Neuberg
1 reference
Kristen E Stevenson
1 reference
Barbara L Asselin
1 reference
Uma H Athale
1 reference
Luis Clavell
1 reference
Peter D Cole
1 reference
Kara M Kelly
1 reference
Eric C Larsen
1 reference
Caroline Laverdière
1 reference
Bruno Michon
1 reference
Marshall Schorin
1 reference
Cindy L Schwartz
1 reference
Harvey J Cohen
1 reference
Lewis B Silverman
1 reference
Stephen E Sallan
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference